Pilot study evaluating the safety and efficacy of open-label olanzapine monotherapy in treatment refractory bipolar disorder mania

Trial Profile

Pilot study evaluating the safety and efficacy of open-label olanzapine monotherapy in treatment refractory bipolar disorder mania

Discontinued
Phase of Trial: Phase III

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Dec 2007 Status changed from in progress to discontinued.
    • 12 Jun 2007 Status changed from suspended to in progress.
    • 02 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top